The relevance of serum albumin among elderly patients with acute decompensated heart failure.

Autor:	Mene-Afejuku TO; Department of Medicine, New York Medical College, Metropolitan Hospital Center, New York, USA., Moisa EA; Department of Medicine, New York Medical College, Metropolitan Hospital Center, New York, USA., Akinlonu A; Department of Medicine, New York Medical College, Metropolitan Hospital Center, New York, USA., Dumancas C; Department of Medicine, New York Medical College, Metropolitan Hospital Center, New York, USA., Veranyan S; Department of Medicine, New York Medical College, Metropolitan Hospital Center, New York, USA., Perez JA; Department of Medicine, New York Medical College, Metropolitan Hospital Center, New York, USA., Salazar P; Department of Medicine, New York Medical College, Metropolitan Hospital Center, New York, USA., Chaudhari S; Department of Medicine, New York Medical College, Metropolitan Hospital Center, New York, USA., Pekler G; Department of Medicine, New York Medical College, Metropolitan Hospital Center, New York, USA., Mushiyev S; Department of Medicine, New York Medical College, Metropolitan Hospital Center, New York, USA., Visco F; Department of Medicine, New York Medical College, Metropolitan Hospital Center, New York, USA.
Jazyk:	angličtina
Zdroj:	Journal of geriatric cardiology : JGC [J Geriatr Cardiol] 2019 Jul; Vol. 16 (7), pp. 522-528.
DOI:	10.11909/j.issn.1671-5411.2019.07.005
Abstrakt:	Objective: To assess the prognostic utility of serum albumin among elderly patients admitted for acute decompensated heart failure (ADHF) in terms of all-cause mortality and also to identify the predictors of hypoalbuminemia. Methods: Retrospective cohort study of 119 elderly patients admitted for ADHF. Elderly patients were defined as patients over the age of 65 years. The patients were followed up for approximately 11 years. Patients with advanced renal failure, liver disease not due to HF, cancer and other causes of low life expectancy were excluded. Hypoalbuminemia was defined as serum albumin ≤ 2.9 g/dL. Results: The study was made up of 65 females and 54 males with age ranging from 65 to 96 years. Of the 119 elderly patients with ADHF, there were 26 deaths. A significantly higher proportion of patients in the mortality group had an admission serum albumin level of ≤ 2.9 g/dL than those surviving ( P = 0.011). After Cox's logistic regression, low albumin ( P = 0.016), elevated direct bilirubin ( P = 0.03), age greater than 85 ( P = 0.008), lack of use of beta blockers ( P = 0.0001) and left ventricular ejection fraction less than 35% ( P = 0.005) increased the risk of death. Elevated serum creatinine ( P = 0.0357) was the only predictor of hypoalbuminemia following multiple linear regression. Conclusions: Hypoalbuminemia may be an unrecognized marker of death in elderly patients with ADHF.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu